M&A Deal Summary

C. R. Bard Acquires LifeStent

On December 7, 2008, C. R. Bard acquired healthcare services company LifeStent for 74M USD

Acquisition Highlights
  • This is C. R. Bard’s 4th transaction in the Healthcare Services sector.
  • This is C. R. Bard’s 13th largest (disclosed) transaction.
  • This is C. R. Bard’s 13th transaction in the United States.
  • This is C. R. Bard’s 2nd transaction in California.

M&A Deal Summary
Date 2008-12-07
Target LifeStent
Sector Healthcare Services
Buyer(s) C. R. Bard
Deal Type Divestiture
Deal Value 74M USD

Target

LifeStent

Irvine, California, United States
LifeStent provides healthcare services. A product family of Edwards Lifesciences Corporation.

Search 192,510 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

C. R. Bard

Murray Hill, New Jersey, United States

website

Category Company
Founded 1907
Sector Medical Products
Employees14,900
Revenue 3.7B USD (2016)
DESCRIPTION
Entrance to C. R. Bard's corporate headquarters in Murray Hill, New Jersey.
Entrance to C. R. Bard's corporate headquarters in Murray Hill, New Jersey.

C. R. Bard, Inc. is a multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology, and surgical specialties. C. R. Bard was formed in 1907 and is based in Murray Hill, New Jersey.

DEAL STATS #
Overall 14 of 23
Sector (Healthcare Services) 4 of 4
Type (Divestiture) 1 of 1
State (California) 2 of 6
Country (United States) 13 of 22
Year (2008) 2 of 2
Size (of disclosed) 13 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-06-05 Specialized Health Products Intl

Bountiful, Utah, United States

Specialized Health Products Intl, Inc.,is a designer, developer, manufacturer and licenser of cost-effective, innovative safety healthcare products.

Buy $68M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-05-05 SensoRx

Irvine, California, United States

SenoRx markets the EnCor(R) stereotactic-guided and MRI-guided breast biopsy systems, the Gel Mark(R) line of breast tissue markers and the Contura(R) balloon catheter for the treatment of breast cancer. The Company is based in Irvine, California.

Buy $200M
Mergr

Product

Company

Legal